---
layout: event-post
serie: Career Development Series
# categories: [blog]
name: Drug Deliveryâ€”the current development and future
tags: []
date-and-time: 2024-05-19, 1â€“2:30 PM ET
location: BioLabs Lecture Hall 1080, (Bri Biological Labs, 16 Divinity Ave, Cambridge, MA 02138)
organizers: ['BTBA']
attend: Register [here](https://forms.gle/qMJ8RpAqa3yhkdFF7)
fb-link: https://www.facebook.com/events/978647460618571
---

âœ¨è™Ÿå¤–è™Ÿå¤–ï¼äº”æœˆçš„æœˆæœƒåˆå³å°‡è¿ä¾†é‡ç£…å˜‰è³“è’è‡¨BTBAæœƒå ´ï¼âœ¨

ğŸŒ·ç¶“æ­·äº†ä¸€å ´COVIDèˆ‡CRISPRåŸºå› æ²»ç™‚é©å‘½ï¼ŒmRNA vaccineã€AAVç­‰è©å½™æ˜¯ä¸æ˜¯å†ç†Ÿæ‚‰ä¸éäº†å‘¢ï¼Ÿä½†æ˜¯ï¼Œä½ çœŸçš„å°è—¥ç‰©è¼¸é€(drug delivery)äº†è§£å—ï¼Ÿä½ æƒ³çŸ¥é“å¾è—¥ç‰©ç”¢ç”Ÿåˆ°çœŸæ­£èƒ½é€å…¥é«”ä¸­ç”¢ç”Ÿæ•ˆæœä¸­é–“æœ‰å¤šå°‘çœ‰çœ‰è§’è§’éœ€è¦è€ƒæ…®å—ï¼Ÿä½ å°æœ‰å“ªäº›æœ€æ–°æŠ€è¡“æ”¹è‰¯è—¥ç‰©è¼¸é€éç¨‹æ„Ÿåˆ°å¥½å¥‡å—ï¼Ÿ

ğŸŒ·å¿«ä¾†åƒåŠ 5/19ç”±BTBAä¸»è¾¦çš„Drug Deliveryåº§è«‡å§ï¼åœ¨é€™å ´æ¼”è¬›è£¡ï¼Œåœ¨è—¥ç‰©è¼¸é€é ˜åŸŸå…·æœ‰è±å¯Œç¶“é©—çš„ç›§å½¥å›åšå£«èˆ‡é™³éŸ»ç«¹åšå£«æœƒé€éæ·±å…¥æ·ºå‡ºçš„æ–¹å¼ä»‹ç´¹å¸¸è¦‹çš„è—¥ç‰©è¼¸é€æ–¹å¼ä¾‹å¦‚adeno-associated virus (AAV)èˆ‡lipid nanoparticle (LNP)ç­‰ä»¥åŠä»–å€‘çš„é‹ä½œåŸç†ã€å„ªå‹¢èˆ‡ç¼ºé»ã€å¸¸è¦‹ç”¨é€”ã€ä»¥åŠå­¸ç•Œèˆ‡æ¥­ç•Œçš„æœ€æ–°ç ”ç©¶æ–¹å‘ã€‚

ğŸŒ·æƒ³è¦è·Ÿä¸Šè—¥ç‰©è¼¸é€çš„æ½®æµã€çœ‹çœ‹æœ‰å¤šå°‘æ„æƒ³ä¸åˆ°çš„æ–°å¥‡æ–¹å¼ä¾†å‚³é€è—¥ç‰©çš„è©±å°±è¶•ç·Šå ±åå§ï¼<https://forms.gle/qMJ8RpAqa3yhkdFF7>

ğŸ—£ï¸æœ¬å¯¦é«”æ´»å‹•å…¨ç¨‹ä»¥ä¸­æ–‡é€²è¡Œ The event will be in Mandarin; hybrid event

â–¶ï¸ ä¸»é¡Œ / Topic: Drug Delivery: the current development and future

ğŸ•˜ Time: 2024-05-19 (Sun)
- 12:30 pm - 01:00 pm (ET) Networking
- 01:00 pm - 2:30 pm (ET) Drug Delivery Talk and Panel
- 02:30 pm - 03:00 pm (ET) Networking
- 03:00 pm - 04:00 pm (ET) BTBA monthly meeting
- 04:00 pm - 05:00 pm (ET) Mentor-Mentee program

ğŸ“ Venue: Biological Laboratories 1080 (16 Divinity Ave, Cambridge, MA 02138) & online link (è«‹å¡«å¯«å ±åè¡¨ï¼Œæœƒè­°é€£çµæœƒåœ¨æ´»å‹•å¹¾å¤©å‰å¯„å‡º)

ğŸ¤ Speakers:
- Jason (Yen-Chun) Lu, Ph.D.
    - Senior Scientist I, ModeX Therapeutics
- Yun-Chu Chen, Ph.D.
    - Scientist, Sarepta Therapeutics

ğŸ¤ Moderator:
- Jerry Chun-Chen Yao
    - Ph.D. Candidate, Harvard University


### Speakers

#### Jason Yen-Chun Lu (ç›§å½¥å›)

Senior Scientist I at ModeX Therapeutics

Dr. Jason (Yen-Chun) Lu obtained his B.S.s in Civil Engineering and Chemical Engineering from National Taiwan University and M.Eng. in Biomedical Engineering and M.S./Ph.D. In Biological Engineering from Cornell University. He joined Prof. Robert Langer and Prof. Daniel Andersonâ€™s group at Boston Childrenâ€™s Hospital and MIT in 2018 and focused on developing therapeutics in type I diabetes and mRNA technology. Currently, he is a Sr. Scientist in a biotech company. Additionally, he is a creator/influencer/blogger/youtuber for scientific education, career development and leadership development. He started his blog and facebook fan page in 2021 to share the trend in biomedical research/ novel biotechnology development, experience in the U.S. graduate school and life in America. Moreover, he has more than 8,800 followers on social media.

Linkedin page: <https://www.linkedin.com/in/jason-yen-chun-lu/>


#### Yun-Chu Chen (é™³éŸ»ç«¹)

Scientist, Sarepta Therapeutics

Dr. Yun-Chu Chen is a driven researcher with a diverse background, specializing in designing multiple drug delivery systems for small/macro molecules and biopharmaceuticals, with a keen focus on controlled release. At Sarepta Therapeutics, Yun-Chu experienced formulating and devising analytical methods for AAV-based drug products/processes, playing a role in advancing therapeutic delivery. Prior to this, as a postdoctoral researcher at Purdue University, Yun-Chu contributed to Eli Lillyâ€™s drug product development by developing various sustained drug release systems throughout formulating a library of polymers and excipients. During her PhD at the University of Bath in the UK, Yun-Chu pioneered protocols for generating nano/micro particles capable of preserving proteins/vaccines from heat denaturation. This groundbreaking method laid the foundation for the establishment of EnsiliTech, a spin-out company. Additionally, during her M.Phil at the University of Manchester, she explored research on optimizing blood clot formation. Notably, her academic journey began with a BSc in Physics, and she garnered valuable industry experience as a semiconductor engineer at PHILIPS.

Linkedin page: <https://www.linkedin.com/in/yunchuchenphd/>


### Moderator

#### Chun-Chen Jerry Yao (å§šä¿Šè¾°)

PhD candidate in Dana-Farber Cancer Institute and Department of Molecular and Cellular Biology, Harvard University

Jerry is a graduate student in Harvardâ€™s Molecules, Cells, and Organisms (MCO) program. He earned his BSc at MIT in Brain and Cognitive Science (BCS), where he optimized an in situ sequencing-by-synthesis method in Ed Boydenâ€™s lab and Fei Chenâ€™s lab; he also studied transcription-translation uncoupling in Bacillus subtilis in Gene-Wei Liâ€™s lab. During his gap year before starting at Harvard, he served the Taiwanese army and then worked with Dan Tawfik at the Weizmann Institute to investigate the origin of peptides and the genetic code in the origin of life. For his Ph.D., he hopes to elucidate the principles of biomolecular evolution of enzyme specificity using protein design, evolutionary biology, and high-throughput experimental approaches.

Linkedin page: <https://www.linkedin.com/in/chun-chen-yao-028944123/>
